Tag Archives | MDV3100 Prostate Cancer

Are you adapting to the changing prostate cancer market?

The prostate cancer market continues to evolve at a fast pace.  Companies with products on the market or in development will need to adapt their marketing strategy to the changing prostate cancer market dynamics.  Some of the recent news includes: MDV3100 shows 4.8 improvement in median overall survival Sally Church, PhD on Pharma Strategy Blog […]

Continue Reading

AUA 2011 Prostate Cancer News

Sally Church on Pharma Strategy Blog has published a video blog (vlog) post on what’s hot in Prostate Cancer at the 2011 AUA (American Urological Association) annual meeting in Washington DC. In her post, Sally reviews presentations by Charles Sawyers and Oliver Sartor.  She discusses new prostate cancer products in development such as MDV3100 and […]

Continue Reading

Sally Church’s interview with Dr Charles Sawyers rated a “must read” by Forbes Health

Sally Church invests a lot of her personal time in writing for Pharma Strategy Blog.  With a focus on the science of new products and treatments in cancer and hematology, Sally willingly shares her passion, knowledge and expertise. It is always a pleasure to receive endorsement from others.  Matthew Herper from Forbes Health kindly highlighted Sally’s […]

Continue Reading